|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
EMD Biosciences, Inc. Releases The Inhibitor SourceBook, The First Comprehensive Guide To Inhibitors For Signal Transduction Research And Drug Discovery
10/19/2005 5:11:46 PM
EMD Biosciences, Inc. (EMD), a major supplier of premium research tools for proteomics and disease pathway analysis through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced the release of the Calbiochem(R) Inhibitor SourceBook(TM). The first of its kind in the industry, this publication represents the most comprehensive listing of inhibitors for signal transduction and drug discovery research. EMD is part of the Life Science and Analytics (LSA) division of Merck KGaA (Darmstadt, Germany) and operates as EMD Biosciences, Inc. in North America and as Merck Biosciences outside North America.
|
|
|
|
|
|
|
|
|
|
|